Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

DiaMedica Therapeutics (DMAC) Receivables - Net (2017 - 2026)

DiaMedica Therapeutics filings provide 10 years of Receivables - Net readings, the most recent being $301000.0 for Q1 2026.

  • Quarterly Receivables - Net rose 18.97% to $301000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $301000.0 through Mar 2026, up 18.97% year-over-year, with the annual reading at $258000.0 for FY2025, 9.32% up from the prior year.
  • Receivables - Net hit $301000.0 in Q1 2026 for DiaMedica Therapeutics, up from $258000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $399000.0 in Q1 2024 and bottomed at $57000.0 in Q1 2023.
  • Average Receivables - Net over 5 years is $228588.2, with a median of $253000.0 recorded in 2025.
  • The largest annual shift saw Receivables - Net tumbled 66.07% in 2023 before it soared 600.0% in 2024.
  • DiaMedica Therapeutics' Receivables - Net stood at $82000.0 in 2022, then soared by 350.0% to $369000.0 in 2023, then crashed by 36.04% to $236000.0 in 2024, then grew by 9.32% to $258000.0 in 2025, then grew by 16.67% to $301000.0 in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Receivables - Net are $301000.0 (Q1 2026), $258000.0 (Q4 2025), and $260000.0 (Q3 2025).